Walleye Trading’s IDEAYA Biosciences IDYA Stock Holding History

Walleye Trading’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,589	Closed	-$448K	–	5029
2023 Q4	$448K	Buy	+12,589	New	+$376K	﹤0.01%	3170

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Walleye Trading's IDYA Position: Q1 2024 in Review

Walleye Trading sold out of IDEAYA Biosciences (IDYA) in Q1 2024, closing a stake of 12,589 shares — an estimated $448K sold.

Walleye Trading first reported a position in IDYA in Q4 2023 and held it in 1 quarter. The position peaked at $448K in Q4 2023. 204 funds tracked by Wall St. Rank hold IDYA as of Q1 2024.

Walleye Trading reported no remaining IDEAYA Biosciences position as of Q1 2024 after selling out during the quarter.
Walleye Trading sold 12,589 IDEAYA Biosciences shares in Q1 2024, an estimated $448K.
Walleye Trading first reported a position in IDEAYA Biosciences in Q4 2023 and held it in 1 quarter.
Walleye Trading's IDEAYA Biosciences position peaked at $448K in Q4 2023.
204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.